Urgent warning from the Ministry of Health, immediately stop using weight loss pills containing 3 extremely dangerous banned substances!
Health protection food Hong Hac Phuc Linh weight loss capsules were found to contain banned substances including sibutramine, desmethyl sibutramine and di-desmethyl sibutramine.
The Food Safety Department (Ministry of Health) received a report from the Ho Chi Minh City Public Health Institute on the results of testing surveillance samples. The health protection food product Hong Hac Phuc Linh weight loss capsules was found to contain banned substances including sibutramine, desmethyl sibutramine and di-desmethyl sibutramine.
The product was discovered to be GMP 2024 Health Protection Food Hong Hac Phuc Linh weight loss capsules (batch number: 01022024, Manufacturing date: February 9, 2024, Expiry date: February 8, 2027) sampled at Nhat Ngan pharmacy, address lot number 13, Cho Gao Trade Center, Cho Gao district, Tien Giang province.
The unit responsible for distribution is Phu Hung Me., JSC, located at No. 16, Lane 159 Lach Tray, Lach Tray Ward, Ngo Quyen District, Hai Phong City. The product is said to be manufactured at the HADU factory, a branch of Hadu Pharmaceutical International Joint Stock Company, located at Lot CN20, Luong Dien Industrial Park, Luong Dien Commune, Cam Giang District, Hai Duong Province.
However, both the distributor and the manufacturer confirmed that they did not produce this batch of products after the food safety and hygiene departments of Hai Phong and Hai Duong worked.
To ensure consumer safety, the Food Safety Department recommends that people do not buy or use products with information matching the above description. If this product is found in circulation, it is necessary to notify the authorities for handling.
Sibutramine is a substance banned from use in food and pharmaceutical products due to its high toxicity. In terms of structure, sibutramine is similar to amphetamine – a dangerous drug. In Vietnam, the regulatory agency has withdrawn all drug registrations containing this active ingredient since 2011.
The other two substances, desmethyl sibutramine and di-desmethyl sibutramine, are also structurally similar to sibutramine and cause serious side effects such as insomnia, anxiety, increased blood sugar, increased blood pressure and heart rate, which are especially dangerous for people with a history of cardiovascular disease, arrhythmia or stroke. These substances also have the potential to interact adversely with other drugs, causing health risks.
